RWJ-51204;Pyrido[1,2-a]benzimidazole-4-carboxamide, 5-(ethoxymethyl)-7-fluoro-N-(2-fluorophenyl)-1,2,3,5-tetrahydro-3-oxo-;RWJ51204,RWJ 51204;RWJ-51204, 10 mM in DMSO
RWJ-51204 is used as an anxiolytic agent; it antagonizes pentylenetetrazol (PTZ)-induced clonic convulsions; it is effective in the conflict test in monkeys; it impairs rotarod performance in rats; it induces sedation, reduces skeletal muscle tone, and causes motor impairment at higher doses.